[O:1]=[C:2]1[CH2:11][CH2:10][C:9]2[C:4](=[CH:5][C:6]([C:12]([O:14][CH2:15][CH2:16][CH2:17][CH2:18][N:19]3[CH2:24][CH2:23][N:22]([C:25]4[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=4[O:31][CH3:32])[CH2:21][CH2:20]3)=[O:13])=[CH:7][CH:8]=2)[NH:3]1.[ClH:33]>>[ClH:33].[O:1]=[C:2]1[CH2:11][CH2:10][C:9]2[C:4](=[CH:5][C:6]([C:12]([O:14][CH2:15][CH2:16][CH2:17][CH2:18][N:19]3[CH2:24][CH2:23][N:22]([C:25]4[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=4[O:31][CH3:32])[CH2:21][CH2:20]3)=[O:13])=[CH:7][CH:8]=2)[NH:3]14-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl 2-oxo-1,2,3,4-tetrahydroquinoline-7-carboxylate hydrochloride (24c) (Scheme 4) was prepared from 23c according to the protocol described for the compound 24a (Example 39). The hydrochloride salt 24c gave satisfactory 1H NMR spectral data. Off-white solid, 0.04 g (43%). MS (ESI): m/z=438.2 (M+H+).